IMG Wealth Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.63K Hold
57
﹤0.01% 393
2026
Q1
$4.92K Hold
57
﹤0.01% 379
2025
Q4
$4.8K Buy
57
+1
+2% +$80 ﹤0.01% 410
2025
Q3
$4.08K Hold
56
﹤0.01% 370
2025
Q2
$3.67K Hold
56
﹤0.01% 386
2025
Q1
$3.93K Buy
56
+1
+2% +$69 ﹤0.01% 247
2024
Q4
$3.64K Buy
+55
New +$3.78K ﹤0.01% 217

Other funds holding IHE

IMG Wealth Management's IHE Position: Q2 2026 in Review

IMG Wealth Management held its iShares US Pharmaceuticals ETF (IHE) position steady in Q2 2026 at 57 shares worth $5.63K. The position accounts for ﹤0.01% of the portfolio, ranked #393.

IMG Wealth Management first reported a position in IHE in Q4 2024 and has held it in 7 quarters since. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • IMG Wealth Management held 57 shares of iShares US Pharmaceuticals ETF worth $5.63K as of Q2 2026.
  • IMG Wealth Management left its iShares US Pharmaceuticals ETF share count unchanged in Q2 2026.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of IMG Wealth Management's portfolio in Q2 2026, its #393 holding.
  • IMG Wealth Management first reported a position in iShares US Pharmaceuticals ETF in Q4 2024 and has held it in 7 quarters since.
  • 209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on IMG Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.